Powered by

BioPlus Specialty Pharmacy Now Dispensing Newly Approved AML Cancer Medication Daurismo(TM)

Dec 04, 2018 - PR Newswire

PR Newswire

ALTAMONTE SPRINGS, Fla., Dec. 4, 2018 /PRNewswire-PRWeb/ -- BioPlus Specialty Pharmacy(BioPlus), a leading innovative specialty pharmacy, is now dispensing the limited distribution oral cancer medication Daurismo(TM) (glasdegib) from Pfizer Inc. The U.S. Food and Drug Administration approved Daurismo on November 21, 2018. With the addition of Daurismo, BioPlus now has access to 62 limited distribution drugs, with 70% of these in the category of cancer medications.